|
| BRIEF COMMUNICATIONS |
|
|
|
| Year : 2005 | Volume
: 23
| Issue : 1 | Page : 41-43 |
| |
Prevalence of HBV and HCV dual infection in patients on haemodialysis
GA Reddy1, KV Dakshinamurthy2, P Neelaprasad2, T Gangadhar2, V Lakshmi1
1 Department of Microbiology, Nizams Institute of Medical Sciences, Panjagutta, Hyderabad - 500 082, Andhra Pradesh, India
2 Department of Nephrology, Nizams Institute of Medical Sciences, Panjagutta, Hyderabad - 500 082, Andhra Pradesh, India
| Date of Submission | 12-Jun-2004 |
| Date of Acceptance | 27-Jul-2004 |
Correspondence Address:
G A Reddy
Department of Microbiology, Nizams Institute of Medical Sciences, Panjagutta, Hyderabad - 500 082, Andhra Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0255-0857.13872
Hepatitis viral infections are important causes of morbidity and mortality in haemodialysis patients. One hundred and thirty four patients attending haemodialysis unit were screened for the presence of HBV and HCV infections. Eight (5.9%) patients were HCV positive while two (1.4%) patients had HBV infection. A dual infection with both the viruses was observed in five patients (3.7%).
Keywords: Chronic renal failure, ELISA, Haemodialysis, Hepatitis
How to cite this article:
Reddy G A, Dakshinamurthy K V, Neelaprasad P, Gangadhar T, Lakshmi V. Prevalence of HBV and HCV dual infection in patients on haemodialysis. Indian J Med Microbiol 2005;23:41-3 |
How to cite this URL:
Reddy G A, Dakshinamurthy K V, Neelaprasad P, Gangadhar T, Lakshmi V. Prevalence of HBV and HCV dual infection in patients on haemodialysis. Indian J Med Microbiol [serial online] 2005 [cited 2020 Nov 28];23:41-3. Available from: https://www.ijmm.org/text.asp?2005/23/1/41/13872 |
Hepatitis B (HBV) and hepatitis C (HCV) viral infections are important causes of morbidity and mortality in haemodialysis patients[1] and pose problems in the management of the patients in the renal dialysis units. Chronic renal failure patients do not clear these viral infections efficiently. Several outbreaks of hepatitis have occurred in these settings[2]. HBV infection is less prevalent than HCV in haemodialysis units.[3] Introduction of HBV vaccination, isolation of HBV positive patients, use of dedicated dialysis machines and regular surveillance for HBV infection dramatically reduced the spread of HBV in this setting[4]. The prevalence of HCV infection among haemodialysis is high and varies between countries (2% to 60%) and between dialysis units within a single country.[5] Dual infection with HBV and HCV leads to more aggressive liver disease.[6] There are very few reports on the prevalence of such dual infections in haemodialysis patients. The present study was undertaken to estimate the prevalence of HBV and HCV dual infection among haemodialysis patients.
| ~ Materials and Methods | |  |
One hundred and thirty four chronic renal failure patients undergoing haemodialysis in the dialysis unit of the nephrology department of Nizam's Institute of Medical Sciences, Hyderabad, between May 2003 and April 2004 were included in the present study. The dialysis unit has eight haemodialysis machines. Among these, one is dedicated for HBV and HBV/HCV co-infected patients and one machine is dedicated for HCV positive patients. Both the machines are placed away from the rest of the machines in an isolated room, so as to avoid cross contamination. The dialyzers of the patients are reused. Reprocessing of the dialyzers of the HBV / HCV positive patients are done in a separate room, away from the rest of the patients. Dedicated nursing staff look after each patient during the dialysis session. Blood samples were drawn from the patients before the start of the first haemodialysis and every month thereafter. The serum samples were screened for HBsAg and anti HCV antibody. All the HBsAg negative patients were given HBV vaccination. Any patient positive for HBsAg or anti HCV or to both were dialyzed on the dedicated machines. Testing of the serum samples of the patient was done by the commercially available third generation Anti HCV ELISA (ORTHO HCV 3.0 ELISA test system with enhanced SAVe) and HBsAg (HEPANOSTIKA HBsAg UNIFORM II, bioMerieux, France) in the microbiology department of our institute. Data were also collected from 1018 patients (non-haemodialysis group) who were screened for HBV and HCV during the same period.
| ~ Results | | |
Out of 134 patients, eight were positive for only anti HCV (5.9%), two patients were positive for HBsAg (1.4%) and dual infection was observed in another five patients (3.7%). All the five patients had a risk factor of history of 2-4 units of blood transfusion before becoming positive.
Three out of five patients, who were initially positive for HBsAg and anti HCV, had history of haemodialysis elsewhere before coming to our centre. The remaining two patients were initially negative for HBsAg and anti HCV. They received the first two doses of HBV vaccination (Engerix B) during their first two months of haemodialysis. Following this, they seroconverted to both HBsAg and anti HCV in a span of one month. While two out of five patients with dual infection expired, two patients continue to be on maintenance haemodialysis and one patient is on continuous ambulatory peritoneal dialysis (CAPD). In 1018 non-haemodialysis patient group, dual infection was observed in only one patient (0.09%).
| ~ Discussion | | |
HBV and HCV share a common route of transmission and can coexist with each other. Haemodialysis patients are at high risk for hepatitis viral infections due to the high number of blood transfusions, prolonged vascular access and the potential for exposure to infected patients and contaminated equipment.[7] Patients with chronic HBV and HCV concurrent infection show a reciprocal inhibition of viral genomes, an association with a severe clinical presentation and an infrequent response to interferon alfa treatment.[8]
Significant immune status disturbances were registered in haemodialysis patients infected with both HBV and HCV compared to patients with HCV alone. A significant risk of cirrhosis development and decompensation of liver function is observed in HBV and HCV infected haemodialysis patients.[9]
Prevalence of HBV and HCV co-infection in non-haemodialysis patients was reported by several authors and ranged between 3 to 56%.[6],[10],[11] A simultaneous study carried out on 75 patients with chronic liver disease by the gastroenterology department of our institute showed a prevalence rate of dual infection of 4% (personal communication).
Studies on prevalence of HCV and HBV coinfection in haemodialysis are rare. Kara et al reported dual infection in three patients out of 67 haemodialysis patients.[12] Kuan et al reported dual infection of 30.4% and it was higher than non haemodialysis patients which was only 3.8%[13] in their series . In our study, we found 3.7% prevalence of dual infection in haemodialysis patients, which was higher than among the non-haemodialysis patients (0.09%).
In conclusion, dual infection with HBV and HCV, though rare, occurs more frequently in certain risk groups. The risk is greater among the CRF patients due to the frequent exposure to blood from transfusions and extracorporeal circulation during haemodialysis. Immunization with HBV vaccine before beginning the dialysis will reduce infection of HBV and strict adherence to universal precautions in the dialysis units may help to decrease the prevalence of both infections among these high-risk patients. However, in our series, two patients developed HBV infection as they had an incomplete vaccination course (two doses only) and were anti HBsAg negative. These patients should be identified early and managed appropriately so as to reduce the risk of long term complications like cirrhosis.
| ~ References | | |
| 1. | Saha D, Agarwal SK. Hepatitis and HIV infection During Haemodialysis. J Indian Med Assoc 2001;99(4):194-199.  |
| 2. | Moreira R, Pinho JRR, Fares J, Oba IT, Cardoso MR, Saraceni CP, Granato C. Prospective Study Of Hepatitis C Virus infection in haemodialysis patients by monthly analysis of HCV RNA and antibodies. Canadian J Microbiol 2003; 49 (8):503-507. |
| 3. | Oesterreicher C, Hammer J, Koch U, Pfeffel F, Sunder-Plassmann G, Petermann D, Muller C. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney International 1995; 48:1967-1971. |
| 4. | Fabrizi F, Poordad F, Martin P. Hepatitis C Infection and the patients with end-stage renal disease. Hepatology 2002; 36(1): 3-10. |
| 5. | Delarocque-Astagneau E, Baffoy N, Thiers V, Simon N, de Valk H, Laperche S, Courouce AM, Astagmeau P, Buisson C, Desenclos JC. Outbreak of Hepatitis C Virus infection in an haemodialysis unit: Potential transmission by haemodialysis machine?. Infection Control And Hospital Epidemiology 2002;23(6):328-334. |
| 6. | Devi KS, Singh NB, Mara J, Singh TB, Singh YM. Seroprevalence of Hepatitis B V virus and Hepatitis C Virus among hepatic disorders and injecting drug users in Manipur- A preliminary report. Ind J Medical Microbiol 2004;22(2):136-137. |
| 7. | Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and Renal Disease: An update. Am J Kidney Diseases 2003;42(4): 631-658. |
| 8. | Sangelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, Onofrio M, Scolastic C, Filippini P. HBV superinfection in Hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology 2002;36(5):1285-1291. |
| 9. | Antonova TV, Kostereva EV, Kunznecova MY, Kubar OI. Viral hepatitis C in haemodialysis. Epi North 2001;2(3):42-44. |
| 10. | Anima X, Kumar M, Minz M. Sharma HP, Shahi SK. Prevalence of Hepatitis B and Hepatitis C virus coinfection in chronic liver disease. Indian J Pathol Microbiol 2001; 44(3):253-255. |
| 11. | Berry N, Chakravati A, Sharma VK, Mathur MD. Coinfection with HBV and HIV in HCV infected chronic liver disease. Indian J Med Microbiol 1998;16(1):44. |
| 12. | Kara IH, Yilmaz ME, Sari, Y, Diizen.S, Usul.Y, Isikoglu B. Seroprevalence and risk factors of HCV in dialysis patients in a University haemodialysis center of south east Anatolia, Turkey. Dialysis and Transplantation 2001;30(11):748-755. |
| 13. | Hung KY, Chen WY, Yang CS, Lee SH, Wu DJ. Hepatitis B and Hepatitis C in haemodialysis patients. Dialysis and Transplantation 1995; 24(3): 135-139. |
| This article has been cited by | | 1 |
Tackling the Hepatitis B disease burden in India |
|
| Pankaj Puri | | Journal of Clinical and Experimental Hepatology. 2014; | | [Pubmed] | [DOI] | | | 2 |
Consensus Statement of HCV Task force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India |
|
| Pankaj Puri,Anil C. Anand,Vivek A. Saraswat,Subrat K. Acharya,Radha K. Dhiman,Rakesh Aggarwal,Shivram P. Singh,Deepak Amarapurkar,Anil Arora,Mohinish Chhabra,Kamal Chetri,Gourdas Choudhuri,Vinod K. Dixit,Ajay Duseja,A.K. Jain,Dharmesh Kapoorz,Premashis Kar,Abraham Koshy,Ashish Kumar,Kaushal Madan,Sri P. Misra,Mohan V.G. Prasad,Aabha Nagral,Amarendra S. Puri,R. Jeyamani,Sanjiv Saigal,Shiv K. Sarin,Samir Shah,P.K. Sharma,Ajit Sood,Sandeep Thareja,Manav Wadhawan | | Journal of Clinical and Experimental Hepatology. 2014; | | [Pubmed] | [DOI] | | | 3 |
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection |
|
| Evangelista Sagnelli,Mariantonietta Pisaturo,Salvatore Martini,Caterina Sagnelli,Pietro Filippini,Nicola Coppola | | Expert Opinion on Pharmacotherapy. 2014; : 1 | | [Pubmed] | [DOI] | | | 4 |
Prevalence of hepatitis B & C viruses among patients on hemodialysis in Lucknow, Uttar Pradesh |
|
| Shantanu Prakash,Amita Jain,S.N. Sankhwar,Kausar Usman,Narayan Prasad,D. Saha,K.P. Singh,Parul Jain,D.D. Singh | | Clinical Epidemiology and Global Health. 2013; | | [Pubmed] | [DOI] | | | 5 |
Hepatitis B virus and hepatitis C virus co-infection: A therapeutic challenge |
|
| Lamine Hamzaoui,Souheil El Bouchtili,Karima Siai,Moufida Mahmoudi,Mohamed Msaddak Azzouz | | Clinics and Research in Hepatology and Gastroenterology. 2013; 37(1): e16 | | [Pubmed] | [DOI] | | | 6 |
Profile of Hepatitis B Virus, Hepatitis C Virus, Hepatitis D Virus and Human Immunodeficiency Virus Infections in Hemodialysis Patients of a Tertiary Care Hospital in Uttarakhand |
|
| Garima Mittal,Pratima Gupta,Bhaskar Thakuria,Gulshan K. Mukhiya,Manish Mittal | | Journal of Clinical and Experimental Hepatology. 2013; 3(1): 24 | | [Pubmed] | [DOI] | | | 7 |
Hepatitis B virus and hepatitis C virus co-infection: A therapeutic challenge |
|
| Hamzaoui, L. and El Bouchtili, S. and Siai, K. and Mahmoudi, M. and Azzouz, M.M. | | Clinics and Research in Hepatology and Gastroenterology. 2013; 37(1): e16-e20 | | [Pubmed] | | | 8 |
Profile of Hepatitis B Virus, Hepatitis C Virus, Hepatitis D Virus and Human Immunodeficiency Virus Infections in Hemodialysis Patients of a Tertiary Care Hospital in Uttarakhand |
|
| Mittal, G. and Gupta, P. and Thakuria, B. and Mukhiya, G.K. and Mittal, M. | | Journal of Clinical and Experimental Hepatology. 2013; 3(1): 24-28 | | [Pubmed] | | | 9 |
Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection |
|
| Abu El Makarem, M.A. and Hamid, M.A. and Aleem, A.A. and Ali, A. and Shatat, M. and Sayed, D. and Deaf, A. and Hamdy, L. and Tony, E.A. | | Hepatitis Monthly. 2012; 12(4): 253-258 | | [Pubmed] | | | 10 |
Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria |
|
| Oje, O.J. and Sule, W.F. and Famurewa, D. | | Viral Immunology. 2012; 25(6): 448-455 | | [Pubmed] | | | 11 |
High prevalence of Mycoplasma Pneumoniae in hepatitis C virus-infected hemodialysis patients |
|
| Kung, C.-M. and Wang, R.-H. and Wang, H.-L. | | Clinical Laboratory. 2012; 58(9-10): 1037-1043 | | [Pubmed] | | | 12 |
SASLT practice guidelines: Management of hepatitis C virus infection |
|
| Alfaleh, F.Z. and Alghamdi, A.S. and Alghamdi, H. and Alqutub, A. and Alswat, K. and Altraif, I. and Sanai, F. and Ismail, M. and Shah, H. | | Saudi Journal of Gastroenterology. 2012; 18(SUPPL. 1): S1-S32 | | [Pubmed] | | | 13 |
Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression? |
|
| Wu, Q. and Liu, Q. | | Hepatology Research. 2012; 42(8): 733-740 | | [Pubmed] | | | 14 |
Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression? : HBV HCV co-infection and HCC |
|
| Qi Wu, Qiang Liu | | Hepatology Research. 2012; : no | | [VIEW] | [DOI] | | | 15 |
Dual Positivity of Hepatitis B Surface Antigen and Anti-Hepatitis C Virus Antibody and Associated Factors Among Apparently Healthy Patients of Ekiti State, Nigeria |
|
| Opeyemi James Oje,Waidi Folorunso Sule,Diran Famurewa | | Viral Immunology. 2012; 25(6): 448 | | [Pubmed] | [DOI] | | | 16 |
Prevalence of Occult Hepatitis B Virus Infection in Hemodialysis Patients From Egypt With or Without Hepatitis C Virus Infection |
|
| Mona A. Abu El Makarem,Mohammed Abdel Hamid,Ashraf Abdel Aleem,Ahmed Ali,Mohammed Shatat,Douaa Sayed,Ali Deaf,Lamia Hamdy,Effat A. Tony | | Hepatitis Monthly. 2012; 12(4): 253 | | [Pubmed] | [DOI] | | | 17 |
Challenges in containing the burden of hepatitis B infection in dialysis and transplant patients in India : Efficacy of HBV vaccination after transplantation |
|
| GULIVER POTSANGBAM, ASHOK YADAV, NIRUPAMA CHANDEL, MANISH RATHI, ASHISH SHARMA, HARBIR S KOHLI, KRISHAN L GUPTA, MUKUT MINZ, VINAY SAKHUJA, VIVEKANAND JHA | | Nephrology. 2011; 16(4): 383 | | [VIEW] | [DOI] | | | 18 |
Hepatitis B virus among maintainence haemodialysis patients: A report from Karachi, Pakistan |
|
| Idrees, M.K. and Batool, S. and Ahmed, E. | | Journal of the Pakistan Medical Association. 2011; 61(12): 1210-1214 | | [Pubmed] | | | 19 |
Challenges in containing the burden of hepatitis B infection in dialysis and transplant patients in India |
|
| Potsangbam, G. and Yadav, A. and Chandel, N. and Rathi, M. and Sharma, A. and Kohli, H.S. and Gupta, K.L. and Minz, M. and Sakhuja, V. and Jha, V. | | Nephrology. 2011; 16(4): 383-388 | | [Pubmed] | | | 20 |
Prevalence of Hepatitis B surface antigen (HBsAg) among visitors of Shashemene General Hospital voluntary counseling and testing center |
|
| Negero, A., Sisay, Z., Medhin, G. | | BMC Research Notes. 2011; 4(art): 35 | | [Pubmed] | | | 21 |
Prevalence and risk factors of Hepatitis C among maintenance hemodialysis patients at a tertiary-care hospital in Coimbatore, India |
|
| Surendra Kumar, P. and Venu, G. and Madhusudhana Rao, A. and Balakrishnan, N. and Saravanan, T. and Sofia Rani, A. and Subba Rao, T.M. | | Journal of Clinical and Diagnostic Research. 2011; 5(4): 725-728 | | [Pubmed] | | | 22 |
Occult hepatitis B infection in chronic hemodialysis patients: Current concepts and strategy |
|
| Hollinger, F.B. and Habibollahi, P. and Daneshmand, A. and Alavian, S.M. | | Hepatitis Monthly. 2010; 10(3): 199-204 | | [Pubmed] | | | 23 |
Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine |
|
| El-Ottol, A.E.-K.Y., Elmanama, A.A., Ayesh, B.M. | | Virology Journal. 2010; 7(art 210) | | [Pubmed] | | | 24 |
Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine |
|
| El-Ottol, A.E.-K.Y. and Elmanama, A.A. and Ayesh, B.M. | | Virology Journal. 2010; 7(210) | | [Pubmed] | | | 25 |
Occult hepatitis B infection in chronic hemodialysis patients: Current concepts and strategy |
|
| Hollinger, F.B., Habibollahi, P., Daneshmand, A., Alavian, S.M. | | Hepatitis Monthly. 2010; 10(3): 199-204 | | [Pubmed] | | | 26 |
Prevalence and association of hepatitis C viremia in hemodialysis patients at a tertiary care hospital |
|
| Agarwal, S.K. | | Indian Journal of Nephrology. 2009; 19(4): 172-173 | | [Pubmed] | | | 27 |
Authorsæ reply |
|
| Jasuja, S., Gupta, A.K., Choudhry, R., Kher, V., Aggarwal, D.K., Mishra, A., Agarwal, M., (...), Raina, V. | | Indian Journal of Nephrology. 2009; 19(4): 173-174 | | [Pubmed] | | | 28 |
Prevalence of hepatitis B and C infection in hemodialysis patients of Rasht (Center of Guilan Province, Northern part of Iran) |
|
| Mansour-Ghanael, F., Sadeghi, A., Mashhour, M.Y., Joukar, F., Besharati, S., Roshan, Z.A., Khosh-Sorur, M. | | Hepatitis Monthly. 2009; 9(1): 45-49 | | [Pubmed] | | | 29 |
Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease |
|
| Saravanan, S., Velu, V., Nandakumar, S., Madhavan, V., Shanmugasundaram, U., Murugavel, K.G., Balakrishnan, P., (...), Thyagarajan, S.P. | | Journal of Microbiology, Immunology and Infection. 2009; 42(2): 122-128 | | [Pubmed] | | | 30 |
Seropositivity of Hepatitis B virus and Hepatitis C virus dual Infection among blood donors in Nyala Teaching Hospital |
|
| Abou, M.A.A., Eltahir, Y.M. | | Virology Journal. 2009; 6(Art no 227) | | [Pubmed] | | | 31 |
Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico |
|
| Calderón, G.M., González-Velázquez, F., González-Bonilla, C.R., Novelo-Garza, B., Terrazas, J.J., Martínez-Rodríguez, M.L., Cortés-Márquez, S.R., (...), Mejía-Bocanegra, M.G. | | Transfusion. 2009; 49(10): 2200-2207 | | [Pubmed] | | | 32 |
Prevalence and association of hepatitis C viremia in hemodialysis patients at a tertiary care hospital |
|
| Agarwal, S.K. | | Indian Journal of Nephrology. 2009; 19(4): 172-173 | | [Pubmed] | | | 33 |
Authorsæ reply |
|
| Jasuja, S. and Gupta, A.K. and Choudhry, R. and Kher, V. and Aggarwal, D.K. and Mishra, A. and Agarwal, M. and Sarin, A. and Mishra, M.K. and Raina, V. | | Indian Journal of Nephrology. 2009; 19(4): 173-174 | | [Pubmed] | | | 34 |
Prevalence of viral infection among Egyptian children with end stage renal disease |
|
| Samra, N.M. and Moustafa, B.H. and Fadel, F.I. | | Australian Journal of Basic and Applied Sciences. 2009; 3(4): 3479-3491 | | [Pubmed] | | | 35 |
Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico |
|
| Gloria M. Calderón,Felipe González-Velázquez,Cesar R. González-Bonilla,Bárbara Novelo-Garza,Jose J. Terrazas,Maria L. Martínez-Rodríguez,Silvia R. Cortés-Márquez,Juan P. Blanco-Flores,Arturo Rodríguez-Rodríguez,Maria A. Del Campo,Rudy Cortés-Gómez,M. Guadalupe Mejía-Bocanegra | | Transfusion. 2009; 49(10): 2200 | | [Pubmed] | [DOI] | | | 36 |
Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment |
|
| Chi-Jen Chu,Shou-Dong Lee | | Journal of Gastroenterology and Hepatology. 2008; 23(4): 512 | | [Pubmed] | [DOI] | | | 37 |
Prevalence of viral hepatitis in hemodialysis patients in Tehran, Iran |
|
| Toosi, M.N., Larti, F., Seifei, S., Abdollahi, A. | | Journal of Gastrointestinal and Liver Diseases. 2008; 17(2): 233-234 | | [Pubmed] | | | 38 |
Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients |
|
| Jain, P., Nijhawan, S. | | World Journal of Gastroenterology. 2008; 14(14): 2288-2289 | | [Pubmed] | | | 39 |
Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment |
|
| Chu, C.-J., Lee, S.-D. | | Journal of Gastroenterology and Hepatology. 2008; 23(4): 512-520 | | [Pubmed] | | | 40 |
Hepatitis B viral infection in maintenance hemodialysis patients: A three year follow-up |
|
| Cao, Y.-L., Wang, S.-X., Zhu, Z.-M. | | World Journal of Gastroenterology. 2007; 13(45): 6037-6040 | | [Pubmed] | | | 41 |
Hepatitis C and B viruses among some high risk groups of Egyptian children |
|
| Kandil, M.E., Rasheed, M.A., Saad, N.E. | | Journal of Medical Sciences. 2007; 7(8): 1259-1267 | | [Pubmed] | | | 42 |
Understanding the Pathogenesis and Management of Hepatitis B/HIV and Hepatitis B/Hepatitis C Virus Coinfection |
|
| Cheruvu, S., Marks, K., Talal, A.H. | | Clinics in Liver Disease. 2007; 11(4): 917-943 | | [Pubmed] | | | 43 |
Understanding the Pathogenesis and Management of Hepatitis B/HIV and Hepatitis B/Hepatitis C Virus Coinfection |
|
| Srinivas Cheruvu,Kristen Marks,Andrew H. Talal | | Clinics in Liver Disease. 2007; 11(4): 917 | | [Pubmed] | [DOI] | | | 44 |
Hepatitis C and B Viruses Among Some High Risk Groups of Egyptian Children
|
|
| Manal E. Kandil ., Maha A. Rasheed ., Nevine E. Saad . | | Journal of Medical Sciences(Faisalabad). 2007; 7(8): 1259 | | [VIEW] | [DOI] | | | 45 |
Prevalence of Occult Hepatitis B and Hepatitis C Virus Infections in Turkish Hemodialysis Patients |
|
| Fahri Yakaryilmaz,Oguz Alp Gurbuz,Sefa Guliter,Ali Mert,Yildiran Songur,Tarkan Karakan,Hatice Keles | | Renal Failure. 2006; 28(8): 729 | | [Pubmed] | [DOI] | | | 46 |
Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection |
|
| Liu, Z., Hou, J. | | International Journal of Medical Sciences. 2006; 3(2): 57-62 | | [Pubmed] | | | 47 |
Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients |
|
| Yakaryilmaz, F., Alp Gurbuz, O., Guliter, S., Mert, A., Songur, Y., Karakan, T., Keles, H. | | Renal Failure. 2006; 28(8): 729-735 | | [Pubmed] | |
|
|
|
|
|
|
|
|
